✦ LIBER ✦

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

✍ Scribed by Hochhaus, A; O'Brien, S G; Guilhot, F; Druker, B J; Branford, S; Foroni, L; Goldman, J M; Müller, M C; Radich, J P; Rudoltz, M

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Six-year follow-up of patients receiving

✍ Hochhaus, A; O'Brien, S G; Guilhot, F; Druker, B J; Branford, S; Foroni, L; Gold 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 608 KB

Expenditure and effectiveness of treatme

✍ Chen, W.; Zhu, J.J. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB

First-line treatment of 102 chronic myel

✍ Viganò, Ilaria; Di Giacomo, Nunzio; Bozzani, Sofia; Antolini, Laura; Piazza, Roc 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 426 KB

PCN63 The Relative Value of Dasatinib Ve

✍ L. Betegon; I. Gilloteau; P. Martin; A. Woolmore; I. Oyagüez 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Molecular responses of late chronic phas

✍ YaZhen Qin; Bin Jiang; Qian Jiang; Hao Jiang; JinLan Li; Yan Zhang; HongHu Zhu; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 117 KB

First line treatment of chronic phase ch

✍ Eskazan, Ahmet Emre; Ayer, Mesut; Kantarcioglu, Bulent; Arica, Deniz; Demirel, N 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB